Ignite Creation Date:
2024-05-06 @ 7:14 PM
Last Modification Date:
2024-10-26 @ 3:03 PM
Study NCT ID:
NCT05947500
Status:
RECRUITING
Last Update Posted:
2024-07-11
First Post:
2023-07-13
Brief Title:
Testing the Combination of Two Anticancer Drugs M1774 Tuvusertib and Avelumab to Evaluate Their Safety and Effectiveness in Treating Merkel Cell Skin Cancer MATRiX Trial
Sponsor:
National Cancer Institute NCI
Organization:
National Cancer Institute NCI
Key Dates - Follows AllAPIJSON File Order
Start Date:
2024-05-21
Start Date Type:
ACTUAL
Primary Completion Date:
2028-01-01
Primary Completion Date Type:
ESTIMATED
Completion Date:
2028-01-01
Completion Date Type:
ESTIMATED
First Submit Date:
2023-07-13
First Submit QC Date:
July 13 2023
Study First Post Date:
2023-07-17
Study First Post Date Type:
ACTUAL
Results First Submit Date:
None
Results First Submit QC Date:
None
Results First Post Date:
None
Results First Post Date Type:
None
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2024-10-22
Last Update Post Date:
2024-07-11
Last Update Post Date Type:
ACTUAL